121 related articles for article (PubMed ID: 35625907)
1. Natural Polyphenols, 1,2,3,4,6-O-Pentagalloyglucose and Proanthocyanidins, as Broad-Spectrum Anticoronaviral Inhibitors Targeting Mpro and RdRp of SARS-CoV-2.
Jin YH; Lee J; Jeon S; Kim S; Min JS; Kwon S
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625907
[TBL] [Abstract][Full Text] [Related]
2. Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitor.
Tan H; Ma C; Wang J
Med Chem Res; 2022; 31(7):1147-1153. PubMed ID: 35578732
[TBL] [Abstract][Full Text] [Related]
3. Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitor.
Tan H; Ma C; Wang J
Res Sq; 2022 Mar; ():. PubMed ID: 35378761
[TBL] [Abstract][Full Text] [Related]
4. [Identifying SARS-CoV-2 main protease inhibitors by a novel sandwich-like fluorescence polarization screening assay].
Yan H; Yan G; Qi H; Liu Z; Liu X; Liu X; Li N; Chen Y
Sheng Wu Gong Cheng Xue Bao; 2022 Jun; 38(6):2352-2364. PubMed ID: 35786485
[TBL] [Abstract][Full Text] [Related]
5. Highly polymerized proanthocyanidins (PAC) components from blueberry leaf and stem significantly inhibit SARS-CoV-2 infection via inhibition of ACE2 and viral 3CLpro enzymes.
Sugamoto K; Tanaka YL; Saito A; Goto Y; Nakayama T; Okabayashi T; Kunitake H; Morishita K
Biochem Biophys Res Commun; 2022 Jul; 615():56-62. PubMed ID: 35605406
[TBL] [Abstract][Full Text] [Related]
6. Identification of polyphenols from
Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
J Biomol Struct Dyn; 2021 Oct; 39(17):6747-6760. PubMed ID: 32762411
[TBL] [Abstract][Full Text] [Related]
7. Novel Investigational Anti-SARS-CoV-2 Agent Ensitrelvir "S-217622": A Very Promising Potential Universal Broad-Spectrum Antiviral at the Therapeutic Frontline of Coronavirus Species.
Eltayb WA; Abdalla M; Rabie AM
ACS Omega; 2023 Feb; 8(6):5234-5246. PubMed ID: 36798145
[TBL] [Abstract][Full Text] [Related]
8. Effective inhibition of coronavirus replication by
Xu H; Li J; Song S; Xiao Z; Chen X; Huang B; Sun M; Su G; Zhou D; Wang G; Hao R; Wang N
Front Biosci (Landmark Ed); 2021 Oct; 26(10):789-798. PubMed ID: 34719206
[No Abstract] [Full Text] [Related]
9. Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2
Singh S; Sk MF; Sonawane A; Kar P; Sadhukhan S
J Biomol Struct Dyn; 2021 Oct; 39(16):6249-6264. PubMed ID: 32720577
[TBL] [Abstract][Full Text] [Related]
10. The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease.
Chiou WC; Chen JC; Chen YT; Yang JM; Hwang LH; Lyu YS; Yang HY; Huang C
Biochem Biophys Res Commun; 2022 Feb; 591():130-136. PubMed ID: 33454058
[TBL] [Abstract][Full Text] [Related]
11. Anticoronaviral Activity of the Natural Phloroglucinols, Dryocrassin ABBA and Filixic Acid ABA from the Rhizome of
Jin YH; Jeon S; Lee J; Kim S; Jang MS; Park CM; Song JH; Kim HR; Kwon S
Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214108
[TBL] [Abstract][Full Text] [Related]
12. Teriflunomide: A possible effective drug for the comprehensive treatment of COVID-19.
Rabie AM
Curr Res Pharmacol Drug Discov; 2021; 2():100055. PubMed ID: 34870153
[TBL] [Abstract][Full Text] [Related]
13. Glycyrrhizic acid conjugates with amino acid methyl esters target the main protease, exhibiting antiviral activity against wild-type and nirmatrelvir-resistant SARS-CoV-2 variants.
Le UNP; Chang YJ; Lu CH; Chen Y; Su WC; Chao ST; Baltina LA; Petrova SF; Li SR; Hung MC; Lai MMC; Baltina LA; Lin CW
Antiviral Res; 2024 May; 227():105920. PubMed ID: 38821317
[TBL] [Abstract][Full Text] [Related]
14. Development of a simple and miniaturized sandwich-like fluorescence polarization assay for rapid screening of SARS-CoV-2 main protease inhibitors.
Yan G; Li D; Lin Y; Fu Z; Qi H; Liu X; Zhang J; Si S; Chen Y
Cell Biosci; 2021 Dec; 11(1):199. PubMed ID: 34865653
[TBL] [Abstract][Full Text] [Related]
15. 1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection.
Chen RH; Yang LJ; Hamdoun S; Chung SK; Lam CW; Zhang KX; Guo X; Xia C; Law BYK; Wong VKW
Front Pharmacol; 2021; 12():634176. PubMed ID: 33897423
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activities of 4H-chromen-4-one scaffold-containing flavonoids against SARS-CoV-2 using computational and
Raj V; Lee JH; Shim JJ; Lee J
J Mol Liq; 2022 May; 353():118775. PubMed ID: 35194277
[TBL] [Abstract][Full Text] [Related]
17. β-Blockers bearing hydroxyethylamine and hydroxyethylene as potential SARS-CoV-2 Mpro inhibitors: rational based design,
Hamed MIA; Darwish KM; Soltane R; Chrouda A; Mostafa A; Abo Shama NM; Elhady SS; Abulkhair HS; Khodir AE; Elmaaty AA; Al-Karmalawy AA
RSC Adv; 2021 Oct; 11(56):35536-35558. PubMed ID: 35493159
[TBL] [Abstract][Full Text] [Related]
18. Remdesivir Strongly Binds to Both RNA-Dependent RNA Polymerase and Main Protease of SARS-CoV-2: Evidence from Molecular Simulations.
Nguyen HL; Thai NQ; Truong DT; Li MS
J Phys Chem B; 2020 Dec; 124(50):11337-11348. PubMed ID: 33264025
[TBL] [Abstract][Full Text] [Related]
19. Biochemical screening for SARS-CoV-2 main protease inhibitors.
Coelho C; Gallo G; Campos CB; Hardy L; Würtele M
PLoS One; 2020; 15(10):e0240079. PubMed ID: 33022015
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2: Origin, Evolution, and Targeting Inhibition.
Ning S; Yu B; Wang Y; Wang F
Front Cell Infect Microbiol; 2021; 11():676451. PubMed ID: 34222046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
